In a report released today, Justin Keywood from Stifel Nicolaus initiated coverage with a Hold rating on Knight Therapeutics (KHTRF). The companys shares ...
The post Knight Therapeutics (KHTRF) Has a New Rating from Stifel Nicolaus appeared first on Smarter Analyst.
In a report released today, ...

https://www.smarteranalyst.com/new-blurbs/knight-therapeutics-khtrf-has-a-new-rating-from-stifel-nicolaus-2/

#SmarterAnalyst